NASDAQ:TRHC - Tabula Rasa HealthCare Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$72.91 +0.20 (+0.28 %)
(As of 08/17/2018 04:00 PM ET)
Previous Close$72.91
Today's Range$71.46 - $73.57
52-Week Range$17.18 - $73.57
Volume249,788 shs
Average Volume340,897 shs
Market Capitalization$1.34 billion
P/E Ratio-1,822.75
Dividend YieldN/A
Beta2.03
Tabula Rasa HealthCare logoTabula Rasa HealthCare, Inc. operates as a healthcare technology company in the United States. It offers medication risk management, pharmacy cost management, and medicare risk adjustment services. The company offers its technology-enabled products and services to prescribers, pharmacists, and healthcare organizations for medication risk management and risk adjustment. Tabula Rasa HealthCare, Inc. was founded in 2009 and is headquartered in Moorestown, New Jersey.

Receive TRHC News and Ratings via Email

Sign-up to receive the latest news and ratings for TRHC and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry Business services, not elsewhere classified
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:TRHC
CUSIPN/A
Phone866-648-2767

Debt

Debt-to-Equity Ratio0.11
Current Ratio0.36
Quick Ratio0.33

Price-To-Earnings

Trailing P/E Ratio-1,822.75
Forward P/E Ratio140.21
P/E Growth5.15

Sales & Book Value

Annual Sales$134.55 million
Price / Sales10.97
Cash Flow$0.5501 per share
Price / Cash132.55
Book Value$6.86 per share
Price / Book10.63

Profitability

EPS (Most Recent Fiscal Year)($0.04)
Net Income$14.29 million
Net Margins-16.78%
Return on Equity4.55%
Return on Assets2.37%

Miscellaneous

Employees536
Outstanding Shares20,240,000
Market Cap$1.34 billion

Tabula Rasa HealthCare (NASDAQ:TRHC) Frequently Asked Questions

What is Tabula Rasa HealthCare's stock symbol?

Tabula Rasa HealthCare trades on the NASDAQ under the ticker symbol "TRHC."

How were Tabula Rasa HealthCare's earnings last quarter?

Tabula Rasa HealthCare Inc (NASDAQ:TRHC) posted its quarterly earnings results on Tuesday, August, 7th. The company reported $0.20 earnings per share for the quarter, topping analysts' consensus estimates of $0.08 by $0.12. The firm had revenue of $48.60 million for the quarter, compared to analyst estimates of $46.73 million. Tabula Rasa HealthCare had a negative net margin of 16.78% and a positive return on equity of 4.55%. View Tabula Rasa HealthCare's Earnings History.

When is Tabula Rasa HealthCare's next earnings date?

Tabula Rasa HealthCare is scheduled to release their next quarterly earnings announcement on Monday, November, 5th 2018. View Earnings Estimates for Tabula Rasa HealthCare.

What price target have analysts set for TRHC?

11 brokers have issued 12-month price targets for Tabula Rasa HealthCare's stock. Their predictions range from $25.00 to $76.00. On average, they anticipate Tabula Rasa HealthCare's stock price to reach $53.50 in the next twelve months. This suggests that the stock has a possible downside of 26.6%. View Analyst Price Targets for Tabula Rasa HealthCare.

What is the consensus analysts' recommendation for Tabula Rasa HealthCare?

11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Tabula Rasa HealthCare in the last year. There are currently 1 hold rating and 10 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Tabula Rasa HealthCare.

Who are some of Tabula Rasa HealthCare's key competitors?

Who are Tabula Rasa HealthCare's key executives?

Tabula Rasa HealthCare's management team includes the folowing people:
  • Dr. Calvin H. Knowlton, Co-Founder, Chairman & CEO (Age 68)
  • Dr. Orsula V. Knowlton BScPharm, PharmD, MBA, Co-Founder, Pres, Chief Marketing & New Bus. Devel. Officer and Director (Age 49)
  • Mr. Brian W. Adams, CFO & Sec. (Age 36)
  • Mr. Michael Greenhalgh BScPharm, RPh, Chief Operating Officer
  • Ms. Andrea Carolan Speers, Corp. Controller & Chief Accounting Officer (Age 37)

When did Tabula Rasa HealthCare IPO?

(TRHC) raised $60 million in an initial public offering on Thursday, September 29th 2016. The company issued 4,300,000 shares at a price of $13.00-$15.00 per share. Wells Fargo Securities, UBS Investment Bank and Piper Jaffray served as the underwriters for the IPO and Baird and Stifel were co-managers.

Has Tabula Rasa HealthCare been receiving favorable news coverage?

Media coverage about TRHC stock has trended somewhat positive recently, according to Accern Sentiment. The research firm identifies negative and positive media coverage by monitoring more than 20 million news and blog sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Tabula Rasa HealthCare earned a media and rumor sentiment score of 0.16 on Accern's scale. They also assigned news coverage about the company an impact score of 46.55 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the stock's share price in the near future. View Recent Headlines for Tabula Rasa HealthCare.

Who are Tabula Rasa HealthCare's major shareholders?

Tabula Rasa HealthCare's stock is owned by a number of of institutional and retail investors. Top institutional investors include BlackRock Inc. (10.59%), Jennison Associates LLC (3.79%), Hood River Capital Management LLC (3.20%), NN Investment Partners Holdings N.V. (2.30%), Emerald Advisers Inc. PA (1.83%) and Braun Stacey Associates Inc. (1.50%). Company insiders that own Tabula Rasa HealthCare stock include Brian W Adams, Bruce Luehrs, Calvin H Knowlton, Glen R Bressner, Gordon Tunstall, Growth Fund 1Q Lp Originate, Joann M Durham and Orsula V Knowlton. View Institutional Ownership Trends for Tabula Rasa HealthCare.

Which institutional investors are selling Tabula Rasa HealthCare stock?

TRHC stock was sold by a variety of institutional investors in the last quarter, including Hood River Capital Management LLC, Waddell & Reed Financial Inc., Wasatch Advisors Inc., EAM Investors LLC, Peregrine Capital Management LLC, Castleark Management LLC, Pier Capital LLC and EAM Global Investors LLC. Company insiders that have sold Tabula Rasa HealthCare company stock in the last year include Bruce Luehrs, Calvin H Knowlton, Gordon Tunstall, Growth Fund 1Q Lp Originate and Orsula V Knowlton. View Insider Buying and Selling for Tabula Rasa HealthCare.

Which institutional investors are buying Tabula Rasa HealthCare stock?

TRHC stock was acquired by a variety of institutional investors in the last quarter, including BlackRock Inc., NN Investment Partners Holdings N.V., Granite Investment Partners LLC, Braun Stacey Associates Inc., Jennison Associates LLC, KBC Group NV, Bollard Group LLC and Russell Investments Group Ltd.. Company insiders that have bought Tabula Rasa HealthCare stock in the last two years include Brian W Adams and Glen R Bressner. View Insider Buying and Selling for Tabula Rasa HealthCare.

How do I buy shares of Tabula Rasa HealthCare?

Shares of TRHC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Tabula Rasa HealthCare's stock price today?

One share of TRHC stock can currently be purchased for approximately $72.91.

How big of a company is Tabula Rasa HealthCare?

Tabula Rasa HealthCare has a market capitalization of $1.34 billion and generates $134.55 million in revenue each year. The company earns $14.29 million in net income (profit) each year or ($0.04) on an earnings per share basis. Tabula Rasa HealthCare employs 536 workers across the globe.

How can I contact Tabula Rasa HealthCare?

Tabula Rasa HealthCare's mailing address is 228 STRAWBRIDGE DRIVE SUITE 100, MOORESTOWN NJ, 08057. The company can be reached via phone at 866-648-2767 or via email at [email protected]


MarketBeat Community Rating for Tabula Rasa HealthCare (NASDAQ TRHC)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  154 (Vote Outperform)
Underperform Votes:  133 (Vote Underperform)
Total Votes:  287
MarketBeat's community ratings are surveys of what our community members think about Tabula Rasa HealthCare and other stocks. Vote "Outperform" if you believe TRHC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe TRHC will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 8/18/2018 by MarketBeat.com Staff

Featured Article: Relative Strength Index

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.